Acta Scientific Cancer Biology (ASCB)

Short Communication Volume 4 Issue 7

Novel Life-Saving Radiotherapy Technology and How it Can be Made Available in the Developing World

Duvern Ramiah*

Radiation Oncologist at Wits University Donald Gordon Medical Centre, Johannesburg, South Africa

*Corresponding Author: Duvern Ramiah, Radiation Oncologist at Wits University Donald Gordon Medical Centre, Johannesburg, South Africa.

Received: June 14, 2020; Published: June 26, 2020

×

 The COVID-19 pandemic has highlighted how globally interconnected health of individuals has become, and how international co-operation is needed to combat disease. This is not just with communicable diseases, but with non-communicable disease like cancer too. Due to the lack of in-person interactions at conferences due to the pandemic, there has been an avalanche of webcasts from vendors selling the newest novel health technologies such as the latest radiotherapy equipment, with presentations from oncologists on the wonderful results that they are getting using these technologies in oncology centres predominantly in the US and Europe. .

×

Citation

Citation: Duvern Ramiah. “Novel Life-Saving Radiotherapy Technology and How it Can be Made Available in the Developing World”.Acta Scientific Cancer Biology 4.7 (2020): 24-26.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US